These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16864975)
1. Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients. Luo LY; Soosaipillai A; Grass L; Diamandis EP Tumour Biol; 2006; 27(5):227-34. PubMed ID: 16864975 [TBL] [Abstract][Full Text] [Related]
2. Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin. Hutchinson S; Luo LY; Yousef GM; Soosaipillai A; Diamandis EP Clin Chem; 2003 May; 49(5):746-51. PubMed ID: 12709365 [TBL] [Abstract][Full Text] [Related]
3. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Luo LY; Grass L; Howarth DJ; Thibault P; Ong H; Diamandis EP Clin Chem; 2001 Feb; 47(2):237-46. PubMed ID: 11159772 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets. Petraki CD; Karavana VN; Revelos KI; Luo LY; Diamandis EP Histochem J; 2002; 34(6-7):313-22. PubMed ID: 12769263 [TBL] [Abstract][Full Text] [Related]
5. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244 [TBL] [Abstract][Full Text] [Related]
7. Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer. Koh SC; Huak CY; Lutan D; Marpuang J; Ketut S; Budiana NG; Saleh AZ; Aziz MF; Winarto H; Pradjatmo H; Hoan NK; Thanh PV; Choolani M J Gynecol Oncol; 2012 Jul; 23(3):175-81. PubMed ID: 22808360 [TBL] [Abstract][Full Text] [Related]
8. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Diamandis EP; Yousef GM; Soosaipillai AR; Grass L; Porter A; Little S; Sotiropoulou G Clin Biochem; 2000 Jul; 33(5):369-75. PubMed ID: 11018688 [TBL] [Abstract][Full Text] [Related]
9. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids. Yousef GM; Kapadia C; Polymeris ME; Borgono C; Hutchinson S; Wasney GA; Soosaipillai A; Diamandis EP Biochim Biophys Acta; 2003 Jul; 1628(2):88-96. PubMed ID: 12890555 [TBL] [Abstract][Full Text] [Related]
10. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk. Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124 [TBL] [Abstract][Full Text] [Related]
11. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Luo LY; Katsaros D; Scorilas A; Fracchioli S; Bellino R; van Gramberen M; de Bruijn H; Henrik A; Stenman UH; Massobrio M; van der Zee AG; Vergote I; Diamandis EP Cancer Res; 2003 Feb; 63(4):807-11. PubMed ID: 12591730 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues. Petraki CD; Gregorakis AK; Papanastasiou PA; Karavana VN; Luo LY; Diamandis EP Prostate Cancer Prostatic Dis; 2003; 6(3):223-7. PubMed ID: 12970725 [TBL] [Abstract][Full Text] [Related]
13. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; BorgoƱo C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Luo LY; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais IA; Howarth DJ; Diamandis EP Clin Cancer Res; 2001 Aug; 7(8):2372-9. PubMed ID: 11489815 [TBL] [Abstract][Full Text] [Related]
15. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. Komatsu N; Saijoh K; Sidiropoulos M; Tsai B; Levesque MA; Elliott MB; Takehara K; Diamandis EP J Invest Dermatol; 2005 Dec; 125(6):1182-9. PubMed ID: 16354188 [TBL] [Abstract][Full Text] [Related]
16. Human kallikrein 10: a novel tumor marker for ovarian carcinoma? Luo LY; Bunting P; Scorilas A; Diamandis EP Clin Chim Acta; 2001 Apr; 306(1-2):111-8. PubMed ID: 11282101 [TBL] [Abstract][Full Text] [Related]
17. Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients. Zarghooni M; Soosaipillai A; Grass L; Scorilas A; Mirazimi N; Diamandis EP Clin Biochem; 2002 May; 35(3):225-31. PubMed ID: 12074831 [TBL] [Abstract][Full Text] [Related]
18. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Diamandis EP; Yousef GM; Soosaipillai AR; Bunting P Clin Biochem; 2000 Oct; 33(7):579-83. PubMed ID: 11124344 [TBL] [Abstract][Full Text] [Related]
19. Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients. Dorn J; Schmitt M; Kates R; Schmalfeldt B; Kiechle M; Scorilas A; Diamandis EP; Harbeck N Clin Cancer Res; 2007 Mar; 13(6):1742-8. PubMed ID: 17363527 [TBL] [Abstract][Full Text] [Related]
20. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]